Ocular Imaging Study Using Advanced OCT

Status

Terminated

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02827071

Enrollment

150

Registered

2016-07-11

Start date

2016-07-01

Completion date

2021-12-09

Last updated

2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Macular Degeneration, Retinal Vascular Disorder

Brief summary

The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 115 Years

Healthy volunteers

Inclusion criteria

• Any patient with abnormal retinal findings as determined by investigators.

Exclusion criteria

* Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging. * Participants who are unable to maintain retinal fixation on a specified target. * Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place. * Patients with media opacity which preclude high quality imaging.

Design outcomes

Primary

Measure	Time frame
Retinal vascular abnormalities imaged by OCT Angiography and en face analysis of macular disorders	2 years

Countries

United States

Outcome results